Ani Pharmaceuticals (ANIP) Net Margin (2011 - 2026)
Ani Pharmaceuticals (ANIP) reported Net Margin of 12.42% for Q1 2026, up 467.0% on a YoY basis from 2.19% in Q1 2025, and up 11.62% sequentially from 11.13% in Q4 2025.
Ani Pharmaceuticals (ANIP) Net Margin (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals (ANIP) has 16 years of Net Margin data on file, last reported at 12.42% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 467.0% year-over-year to 12.42%; the trailing twelve-month figure through Mar 2026 stood at 9.89% (up 1326.0% YoY), and the FY2025 full-year result was 8.74%, up 1202.0% from the prior year.
- Net Margin improved to 12.42% in Q1 2026, from 11.13% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 12.95% in Q1 2024 to a low of 31.85% in Q1 2022.
- A 5-year average of 1.12% and a median of 0.97% in 2023 frame the typical range for Net Margin.
- Peak annual rise in Net Margin reached 3499 bps in 2022, while the deepest fall reached 3257 bps in 2022.
- Tracing ANIP's Net Margin over 5 years: stood at 4.93% in 2022, then surged by 112 bps to 0.57% in 2023, then tumbled by 1085 bps to 5.61% in 2024, then jumped by 299 bps to 11.13% in 2025, then increased by 12 bps to 12.42% in 2026.
- Business Quant data shows ANIP's Net Margin at 12.42% in Q1 2026, 11.13% in Q4 2025, and 11.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 9.29% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 26.57% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -33.66% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 35.18% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 5.03% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 24.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 4.16% |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.33 Bn | 143.88 Mn | 12.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.42% |
| Dec 31, 2025 | 11.13% |
| Sep 30, 2025 | 11.53% |
| Jun 30, 2025 | 3.85% |
| Mar 31, 2025 | 7.75% |
| Dec 31, 2024 | -5.61% |
| Sep 30, 2024 | -16.57% |
| Jun 30, 2024 | -1.95% |
| Mar 31, 2024 | 12.95% |
| Dec 31, 2023 | 0.57% |
| Sep 30, 2023 | 7.23% |
| Jun 30, 2023 | 5.01% |
| Mar 31, 2023 | 0.97% |
| Dec 31, 2022 | -4.93% |
| Sep 30, 2022 | -10.74% |
| Jun 30, 2022 | -20.76% |
| Mar 31, 2022 | -31.85% |
| Dec 31, 2021 | -39.93% |
| Sep 30, 2021 | -8.54% |
| Jun 30, 2021 | -29.01% |